|Bid||9.50 x 800|
|Ask||12.09 x 800|
|Day's range||11.09 - 12.01|
|52-week range||7.40 - 13.97|
|Beta (5Y monthly)||0.95|
|PE ratio (TTM)||65.99|
|Earnings date||27 Feb 2023 - 03 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||25.00|
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...
Cara Therapeutics ( NASDAQ:CARA ) Third Quarter 2022 Results Key Financial Results Revenue: US$10.8m (down 47% from 3Q...
Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?